Combination Therapy for Chronic Stroke-Induced Impairment
Project Number1R21NS057282-01A1
Contact PI/Project LeaderLEASURE, J. LEIGH
Awardee OrganizationUNIVERSITY OF HOUSTON
Description
Abstract Text
DESCRIPTION (provided by applicant): The objective of the proposed experiment is to determine whether chronic stroke-induced impairment in aged animals can be ameliorated with a combination of two plasticity-enhancing treatments; exposure to environmental enrichment and treatment with chondroitinase ABC (cABC), which has been previously shown to enhance axonal outgrowth after spinal cord injury. This proposal seeks to break new ground in three under-explored areas. First, the potential of cABC to promote axonal plasticity after stroke has not been investigated. Second, the combination of cABC and environmental enrichment has not been attempted in any model of neurological disease. Third, very little research has addressed stroke injury in an aged system, despite the prevalence of stroke among elderly humans, and the special considerations inherent to the aged central nervous system. We propose, therefore, to examine aged rats and to address stroke-related motor impairment in the chronic phase of injury. This objective conforms to NINDS's mission to reduce the burden of neurological disease by realizing the translational potential of basic research findings. Focal cerebral ischemic lesions will be made in aged rats with the vasoconstrictor endothelin-1 (ET-1). Subsequently, animals will remain in standard social housing for one month in order to model chronic, untreated impairment in humans. Animals will then be transferred to enriched housing and treated with cABC. Behavioral testing will continue for an additional three months in order to determine whether the combination of enriched housing and cABC can ameliorate chronic stroke-induced impairment. Finally, animals will be sacrificed and brain tissue processed for markers of axonal outgrowth.
We anticipate that enriched environment alone will be insufficient to produce a measurable behavioral improvement, but that the combination of enriched housing and cABC will reduce impairment and enhance axonal plasticity. This application is relevant to public health because stroke survivors are prevalent among the elderly in our society. The proposed experiment will test a potential treatment for chronic stroke-related impairment in the aged brain.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAgeAgingAnimalsAreaAxonBasic ScienceBehavioralBiological ModelsBlood flowBrainBrain InjuriesCell NucleusCerebral IschemiaCerebrumChondroitin ABC LyaseChondroitin Sulfate ProteoglycanChondroitin SulfatesChronicChronic PhaseCombined Modality TherapyComplexDenervationDepositionDistalElderlyElementsEndothelin-1EnvironmentEnzymesExploratory/Developmental GrantExposure toFiberForelimbGlycosaminoglycansGrowthHousingHumanImpairmentInfarctionInjuryIpsilateralIschemiaLesionMeasurableMeasuresMissionModelingNatural regenerationNatureNeuraxisNeurological ModelsNeuronsPersonal SatisfactionPontine structurePredictive ValuePrevalencePublic HealthRattusRecommendationRecovery of FunctionRed nucleus structureRehabilitation therapyResearchResearch SupportSocietiesSpinal CordSpinal cord injuryStagingStandards of Weights and MeasuresStrokeSurvivorsSystemTestingTherapeuticTissuesVasoconstrictor AgentsWestern Blottingagedaging brainaxon regenerationbehavior testbrain tissuecentral nervous system injurychronic strokeimprovedinjuredischemic lesionmotor deficitmotor impairmentnervous system disorderpre-clinicalpreclinical studypreventrelating to nervous systemresearch studysocialtissue processingtreatment program
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
036837920
UEI
QKWEF8XLMTT3
Project Start Date
01-September-2007
Project End Date
31-July-2009
Budget Start Date
01-September-2007
Budget End Date
31-July-2008
Project Funding Information for 2007
Total Funding
$177,984
Direct Costs
$131,250
Indirect Costs
$46,734
Year
Funding IC
FY Total Cost by IC
2007
National Institute of Neurological Disorders and Stroke
$177,984
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21NS057282-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21NS057282-01A1
Patents
No Patents information available for 1R21NS057282-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21NS057282-01A1
Clinical Studies
No Clinical Studies information available for 1R21NS057282-01A1
News and More
Related News Releases
No news release information available for 1R21NS057282-01A1
History
No Historical information available for 1R21NS057282-01A1
Similar Projects
No Similar Projects information available for 1R21NS057282-01A1